Chen Y, Wang S, Lu S
Vaccines (Basel). 2015; 2(1):138-59.
PMID: 26344472
PMC: 4494200.
DOI: 10.3390/vaccines2010138.
Chinombe N, Ruhanya V
Pan Afr Med J. 2015; 20:386.
PMID: 26185576
PMC: 4499268.
DOI: 10.11604/pamj.2015.20.386.4660.
Chen Y, Yang S, Ho E
Chromatographia. 2014; 77(23-24):1713-1720.
PMID: 25477555
PMC: 4244548.
DOI: 10.1007/s10337-014-2777-7.
Villarreal D, Talbott K, Choo D, Shedlock D, Weiner D
Expert Rev Vaccines. 2013; 12(5):537-54.
PMID: 23659301
PMC: 4317298.
DOI: 10.1586/erv.13.33.
McCoy L, Weiss R
J Exp Med. 2013; 210(2):209-23.
PMID: 23401570
PMC: 3570100.
DOI: 10.1084/jem.20121827.
Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
Hallengard D, Applequist S, Nystrom S, Maltais A, Marovich M, Moss B
Viral Immunol. 2012; 25(5):423-32.
PMID: 23035853
PMC: 10970668.
DOI: 10.1089/vim.2012.0046.
Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles.
Lin S, Lin Y, Chong P, Wu S
PLoS One. 2012; 7(6):e39075.
PMID: 22720032
PMC: 3374787.
DOI: 10.1371/journal.pone.0039075.
Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.
Arrode-Bruses G, Hegde R, Jin Y, Liu Z, Narayan O, Chebloune Y
Vaccine. 2012; 30(19):2956-62.
PMID: 22387218
PMC: 3341415.
DOI: 10.1016/j.vaccine.2012.02.050.
Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells.
Jaworski J, Krebs S, Trovato M, Kovarik D, Brower Z, Sutton W
PLoS One. 2012; 7(2):e31464.
PMID: 22359593
PMC: 3281069.
DOI: 10.1371/journal.pone.0031464.
Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.
Feng Y, McKee K, Tran K, ODell S, Schmidt S, Phogat A
J Biol Chem. 2011; 287(8):5673-86.
PMID: 22167180
PMC: 3285340.
DOI: 10.1074/jbc.M111.317776.
Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.
Li W, Chen Q, Ye J, Xie Z, Chen J, Zhang L
Parasitol Res. 2011; 109(3):637-44.
PMID: 21404064
DOI: 10.1007/s00436-011-2296-5.
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.
Ranasinghe C, Eyers F, Stambas J, Boyle D, Ramshaw I, Ramsay A
Vaccine. 2011; 29(16):3008-20.
PMID: 21352941
PMC: 3244379.
DOI: 10.1016/j.vaccine.2011.01.106.
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.
Caivano A, Doria-Rose N, Buelow B, Sartorius R, Trovato M, DApice L
Virology. 2010; 407(2):296-305.
PMID: 20850858
PMC: 3275809.
DOI: 10.1016/j.virol.2010.08.026.
DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.
Davtyan H, Mkrtichyan M, Movsesyan N, Petrushina I, Mamikonyan G, Cribbs D
Gene Ther. 2009; 17(2):261-71.
PMID: 19865176
PMC: 2820600.
DOI: 10.1038/gt.2009.140.
Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).
Vaine M, Lu S, Wang S
BioDrugs. 2009; 23(3):137-53.
PMID: 19627166
PMC: 3764985.
DOI: 10.2165/00063030-200923030-00001.
Heterologous prime-boost vaccination.
Lu S
Curr Opin Immunol. 2009; 21(3):346-51.
PMID: 19500964
PMC: 3743086.
DOI: 10.1016/j.coi.2009.05.016.
Viral sequence diversity: challenges for AIDS vaccine designs.
McBurney S, Ross T
Expert Rev Vaccines. 2008; 7(9):1405-17.
PMID: 18980542
PMC: 2702717.
DOI: 10.1586/14760584.7.9.1405.
Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity.
Dey B, Pancera M, Svehla K, Shu Y, Xiang S, Vainshtein J
J Virol. 2007; 81(11):5579-93.
PMID: 17360741
PMC: 1900256.
DOI: 10.1128/JVI.02500-06.
Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models.
Li Y, Kang H, Babiuk L, Liu Q
World J Gastroenterol. 2006; 12(44):7126-35.
PMID: 17131474
PMC: 4087773.
DOI: 10.3748/wjg.v12.i44.7126.
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs.
Shu Y, Winfrey S, Yang Z, Xu L, Rao S, Srivastava I
Vaccine. 2006; 25(8):1398-408.
PMID: 17113201
PMC: 1821094.
DOI: 10.1016/j.vaccine.2006.10.046.